Abstract
The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients
suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the
cooperative effort of a multidisciplinary and multicenter group of collaborators, the
etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular
its more severe form of NASH and its complications.

